In my experience, when company managers put out announcements such as this - which are ...uh... decidedly light on new material information that is relevant - they seldom do so for the sake of it.
So in your opinion what would the reason be for the announcement if it's not to advise the decision of the DMC to continue the trial with no amendments and of course them not having done it for the 'sake of it' ?![]()
- Forums
- ASX - By Stock
- MSB
- Ann: MSB Clinical Program Update For MPC-150-IM In Heart Failure
MSB
mesoblast limited
Add to My Watchlist
12.3%
!
$2.43
Ann: MSB Clinical Program Update For MPC-150-IM In Heart Failure, page-15
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
